{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:18:09Z","timestamp":1761059889773},"reference-count":53,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH082784"],"award-info":[{"award-number":["R01MH082784"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["2UL1TR000433-06"],"award-info":[{"award-number":["2UL1TR000433-06"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007800","name":"Diabetes Research and Training Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007800","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK020572"],"award-info":[{"award-number":["DK020572"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["schres-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.schres.2015.02.006","type":"journal-article","created":{"date-parts":[[2015,2,22]],"date-time":"2015-02-22T23:00:16Z","timestamp":1424646016000},"page":"115-121","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Endothelial function, folate pharmacogenomics, and neurocognition in psychotic disorders"],"prefix":"10.1016","volume":"164","author":[{"given":"Tyler","family":"Grove","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Dalack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicki","family":"Ellingrod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.schres.2015.02.006_bb0005","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1093\/hmg\/ddl253","article-title":"Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder","volume":"15","author":"Abdolmaleky","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.schres.2015.02.006_bb0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"issue":"7","key":"10.1016\/j.schres.2015.02.006_bb0020","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.neuropsychologia.2012.05.017","article-title":"Dorsolateral prefrontal contributions to human intelligence","volume":"51","author":"Barbey","year":"2013","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.schres.2015.02.006_bb0025","series-title":"Manual for the Beck Depression Inventory-II","author":"Beck","year":"1996"},{"issue":"2","key":"10.1016\/j.schres.2015.02.006_bb0030","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","article-title":"Endothelial dysfunction: a marker of atherosclerotic risk","volume":"23","author":"Bonetti","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.schres.2015.02.006_bb0035","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.jacc.2004.08.062","article-title":"Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia","volume":"44","author":"Bonetti","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.schres.2015.02.006_bb0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40291-013-0017-8","article-title":"Detection of metabolic syndrome in schizophrenia and implications for antipsychotic therapy: is there a role for folate?","volume":"17","author":"Burghardt","year":"2013","journal-title":"Mol. Diagn. Ther."},{"issue":"4","key":"10.1016\/j.schres.2015.02.006_bb0045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/13546805.2012.698100","article-title":"COMT influences on prefrontal and striatal blood oxygenation level-dependent responses during working memory among individuals with schizophrenia, their siblings, and healthy controls","volume":"18","author":"Ceaser","year":"2013","journal-title":"Cogn. Neuropsychiatry"},{"issue":"5","key":"10.1016\/j.schres.2015.02.006_bb0050","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/425589","article-title":"Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain","volume":"75","author":"Chen","year":"2004","journal-title":"Am. J. Hum. Genet."},{"issue":"10","key":"10.1016\/j.schres.2015.02.006_bb0055","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1532-5415.2007.01378.x","article-title":"Assessment of endothelial function in Alzheimer's disease: is Alzheimer's disease a vascular disease?","volume":"55","author":"Dede","year":"2007","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1\u20133","key":"10.1016\/j.schres.2015.02.006_bb0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.schres.2007.09.030","article-title":"Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C\/T and 1298A\/C variants","volume":"98","author":"Ellingrod","year":"2008","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2015.02.006_bb0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2011.03.031","article-title":"Dietary, lifestyle and pharmacogenetic factors associated with arteriole endothelial-dependent vasodilatation in schizophrenia patients treated with atypical antipsychotics (AAPs)","volume":"130","author":"Ellingrod","year":"2011","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2015.02.006_bb0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/JCP.0b013e3182485888","article-title":"Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics","volume":"32","author":"Ellingrod","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.schres.2015.02.006_bb0075","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jpsychires.2013.07.011","article-title":"Schizophrenia and the risk of cardiovascular diseases: a meta-analysis of thirteen cohort studies","volume":"47","author":"Fan","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2015.02.006_bb0080","series-title":"Discovering Statistics Using SPSS","author":"Field","year":"2009"},{"key":"10.1016\/j.schres.2015.02.006_bb0085","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders SCID-I: Clinician Version, Administration Booklet","author":"First","year":"1997"},{"issue":"10","key":"10.1016\/j.schres.2015.02.006_bb0090","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1176\/appi.ajp.2010.09091328","article-title":"The effects of hypertension and body mass index on cognition in schizophrenia","volume":"167","author":"Friedman","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2015.02.006_bb0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/clc.4960270307","article-title":"Peripheral arterial tonometry: a diagnostic method for detection of myocardial ischemia induced during mental stress tests: a pilot study","volume":"27","author":"Goor","year":"2004","journal-title":"Clin. Cardiol."},{"issue":"3","key":"10.1016\/j.schres.2015.02.006_bb0100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1176\/ajp.153.3.321","article-title":"What are the functional consequences of neurocognitive deficits in schizophrenia?","volume":"153","author":"Green","year":"1996","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2015.02.006_bb0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2004.09.009","article-title":"Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS","volume":"72","author":"Green","year":"2004","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2015.02.006_bb0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/oxfordjournals.schbul.a033430","article-title":"Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the \u201cright stuff\u201d?","volume":"26","author":"Green","year":"2000","journal-title":"Schizophr. Bull."},{"issue":"12","key":"10.1016\/j.schres.2015.02.006_bb0115","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.4065\/79.12.1514","article-title":"Effect of long-term hormone replacement therapy on coronary endothelial function in postmenopausal women","volume":"79","author":"Halligan","year":"2004","journal-title":"Mayo Clin. Proc."},{"issue":"1","key":"10.1016\/j.schres.2015.02.006_bb0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0920-9964(98)00109-1","article-title":"Convergence of cognitive and adaptive decline in late-life schizophrenia","volume":"35","author":"Harvey","year":"1999","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2015.02.006_bb9000","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/01.ATV.0000053181.59330.79","article-title":"Triglyceride-rich lipoproteins and vascular function","volume":"23","author":"Haynes","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.schres.2015.02.006_bb0125","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","article-title":"Schizophrenia and increased risks of cardiovascular disease","volume":"150","author":"Hennekens","year":"2005","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.schres.2015.02.006_bb0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2014.12.056","article-title":"Weight loss improves fasting flow-mediated vasodilation in adults: a meta-analysis of intervention studies","volume":"239","author":"Joris","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.schres.2015.02.006_bb0135","series-title":"Brief Assessment of Cognition in Schizophrenia (BACS)","author":"Keefe","year":"1999"},{"issue":"2\u20133","key":"10.1016\/j.schres.2015.02.006_bb0140","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.schres.2003.09.011","article-title":"The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery","volume":"68","author":"Keefe","year":"2004","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2015.02.006_bb0145","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.schres.2008.03.024","article-title":"Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS)","volume":"102","author":"Keefe","year":"2008","journal-title":"Schizophr. Res."},{"issue":"16","key":"10.1016\/j.schres.2015.02.006_bb0150","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1001\/jama.288.16.2023","article-title":"MTHFR 677C\u2192T polymorphism and risk of coronary heart disease: a meta-analysis","volume":"288","author":"Klerk","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.schres.2015.02.006_bb0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neulet.2013.01.012","article-title":"COMT and MTHFR polymorphisms interaction on cognition in schizophrenia: an exploratory study","volume":"537","author":"Kontis","year":"2013","journal-title":"Neurosci. Lett."},{"issue":"13","key":"10.1016\/j.schres.2015.02.006_bb0160","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jacc.2006.11.039","article-title":"Arterial ultrasonography and tonometry as adjuncts to cardiovascular risk stratification","volume":"49","author":"Kullo","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.schres.2015.02.006_bb0165","first-page":"246","article-title":"Peripheral arterial tonometry: a novel and sensitive non-invasive monitor of brief arousals during sleep","volume":"2","author":"Lavie","year":"2000","journal-title":"Isr. Med. Assoc. J."},{"issue":"2","key":"10.1016\/j.schres.2015.02.006_bb0170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jpsychires.2011.11.001","article-title":"Genome-wide study identifies PTPRO and WDR72 and FOXQ1-SUMO1P1 interaction associated with neurocognitive function","volume":"46","author":"LeBlanc","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.schres.2015.02.006_bb0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/JCP.0000000000000258","article-title":"The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia: a pilot study","volume":"35","author":"Maia-de-Oliveira","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.schres.2015.02.006_bb0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/09629359791875","article-title":"Nitric oxide function in atherosclerosis","volume":"6","author":"Matthys","year":"1997","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.schres.2015.02.006_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.schres.2005.07.015","article-title":"The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome","volume":"80","author":"Meyer","year":"2005","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2015.02.006_bb0190","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/07853890701854702","article-title":"Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction","volume":"40","author":"Munzel","year":"2008","journal-title":"Ann. Med."},{"issue":"3","key":"10.1016\/j.schres.2015.02.006_bb0195","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.CIR.0000020190.45892.75","article-title":"AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases","volume":"106","author":"Pearson","year":"2002","journal-title":"Circulation"},{"issue":"1\u20133","key":"10.1016\/j.schres.2015.02.006_bb9009","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.schres.2013.09.020","article-title":"Unraveling the relationship between obesity, schizophrenia and cognition","volume":"151","author":"Rashid","year":"2013","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2015.02.006_bb0200","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.atherosclerosis.2011.08.032","article-title":"The metabolic syndrome, atherosclerosis and cognitive functioning in a non-demented population: the Hoorn Study","volume":"219","author":"Reijmer","year":"2011","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.schres.2015.02.006_bb0205","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11682-010-9111-2","article-title":"MTHFR 677C>T effects on anterior cingulate structure and function during response monitoring in schizophrenia: a preliminary study","volume":"5","author":"Roffman","year":"2011","journal-title":"Brain Imaging Behav."},{"issue":"45","key":"10.1016\/j.schres.2015.02.006_bb0210","doi-asserted-by":"crossref","first-page":"17573","DOI":"10.1073\/pnas.0803727105","article-title":"MTHFR 677C\u2192T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val\u2192Met","volume":"105","author":"Roffman","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.schres.2015.02.006_bb0215","doi-asserted-by":"crossref","first-page":"e25253","DOI":"10.1371\/journal.pone.0025253","article-title":"A hypomethylating variant of MTHFR, 677C>T, blunts the neural response to errors in patients with schizophrenia and healthy individuals","volume":"6","author":"Roffman","year":"2011","journal-title":"PLoS One"},{"issue":"1\u20133","key":"10.1016\/j.schres.2015.02.006_bb0220","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.schres.2007.01.003","article-title":"Effects of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism on executive function in schizophrenia","volume":"92","author":"Roffman","year":"2007","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.schres.2015.02.006_bb0225","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/ajmg.b.30684","article-title":"Interactive effects of COMT Val108\/158Met and MTHFR C677T on executive function in schizophrenia","volume":"147B","author":"Roffman","year":"2008","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"6423","key":"10.1016\/j.schres.2015.02.006_bb0230","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: a perspective for the 1990s","volume":"362","author":"Ross","year":"1993","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.schres.2015.02.006_bb9900","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis - an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.schres.2015.02.006_bb0235","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/eurheartj\/ehq010","article-title":"Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events","volume":"31","author":"Rubinshtein","year":"2010","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.schres.2015.02.006_bb0240","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/PSY.0b013e31812f7b8e","article-title":"Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression","volume":"69","author":"Smith","year":"2007","journal-title":"Psychosom. Med."},{"issue":"6","key":"10.1016\/j.schres.2015.02.006_bb0245","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/ajmg.b.30700","article-title":"Polymorphisms in the catechol-O-methyltransferase (COMT) gene influence plasma total homocysteine levels","volume":"147B","author":"Tunbridge","year":"2008","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"2","key":"10.1016\/j.schres.2015.02.006_bb0250","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.numecd.2009.08.006","article-title":"Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management","volume":"20","author":"Tziomalos","year":"2010","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.schres.2015.02.006_bb0255","doi-asserted-by":"crossref","DOI":"10.1007\/s12013-015-0526-7","article-title":"The endothelium as a target for the treatment of heart failure","author":"Yang","year":"2015","journal-title":"Cell Biochem. Biophys."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641500081X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641500081X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T19:55:18Z","timestamp":1537818918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099641500081X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":53,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S092099641500081X"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2015.02.006","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelial function, folate pharmacogenomics, and neurocognition in psychotic disorders","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2015.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}